Adherence to Adding ICS to Rescue Therapy in a Pragmatic Trial with Adults with Asthma– a Pilot Study
Rationale Using inhaled corticosteroids (ICS) concomitantly with rescue inhalers (Patient-Activated Reliever-Triggered ICS; ‘PARTICS’) reduces asthma exacerbations in efficacy trials, but has not been tested in pragmatic trials with highly-impacted asthma populations. Barriers to completing study pr...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB209-AB209 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Rationale Using inhaled corticosteroids (ICS) concomitantly with rescue inhalers (Patient-Activated Reliever-Triggered ICS; ‘PARTICS’) reduces asthma exacerbations in efficacy trials, but has not been tested in pragmatic trials with highly-impacted asthma populations. Barriers to completing study procedures included having difficulty with log-in access to electronic questionnaires (30%, 38% at 6, 12 weeks, respectively), remembering to use ICS and rescue inhalers together (20%), and obtaining refills (19%). |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2017.12.662 |